Shanghai Ovarian Cancer and Family Care Project
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
- Status
- RECRUITING
- Phase
- N/A
Doppler Ultrasound and CT Versus Laparoscopy in Assessment of Ovarian Malignancy
- Status
- RECRUITING
- Phase
- N/A
Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice
- Status
- RECRUITING
- Phase
- N/A
Patients Derived Organoids in Ovarian Cancer
- Status
- RECRUITING
- Phase
- NA
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy
- Status
- RECRUITING
- Phase
- PHASE2
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
- Status
- RECRUITING
- Phase
- NA
Ovarian Tumor Organotypic Slices Cultures for functionAl Drug Testing and Therapy Response Prediction
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145
- Status
- COMPLETED
- Phase
- PHASE1
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib
- Status
- UNKNOWN
- Phase
- N/A
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
- Status
- RECRUITING
- Phase
- NA
PRO for Fighting FT in Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
- Status
- RECRUITING
- Phase
- N/A
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
- Status
- RECRUITING
- Phase
- N/A